Skip to main content
TipRanks
Go Ultimate75% OFF

Crispr Therapeutics AG (1CG) Q2 2021 Earnings Report

2 Followers

CH:1CG Q2 2021 EPS Results

Actual EPS
CHF 7.79
Consensus EPS
CHF 2.91
Beat/Miss
Beat by +CHF 4.88
One Year Ago EPS
-CHF 1.07

CH:1CG Q2 2021 Revenue Results

Actual Revenue
CHF 743.46M
Expected Revenue
CHF 743.04M
Beat/Miss
Beat by +CHF 425.09K
YoY Revenue Growth
+2046947.73%

Earnings Announcement Details

Quarter
Q2 2021
Date
07/29/2021
Time
After Close
Conference Call
Thursday, July 29, 2021
CH:1CG Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:1CG Earnings History

CH:1CG earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)-0.97--1.13――
Nov 02, 20262026 (Q3)-0.86-0.95-0.971.71% (+0.02)
Aug 03, 20262026 (Q2)-0.99-0.78-1.9860.83% (+1.21)
May 04, 20262026 (Q1)-1.01-1.06-1.318.99% (+0.25)
Feb 12, 20262025 (Q4)-0.96-1.13-0.36-211.36% (-0.77)
Nov 10, 20252025 (Q3)-1.04-0.97-0.83-15.84% (-0.13)
Aug 04, 20252025 (Q2)-1.16-1.98-1.23-61.07% (-0.75)
May 06, 20252025 (Q1)-1.03-1.30-1.18-10.49% (-0.12)
Feb 11, 20252024 (Q4)-0.99-0.360.91-140.00% (-1.27)
Nov 05, 20242024 (Q3)-1.16-0.83-1.1628.37% (+0.33)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed